VANCOUVER, BC / ACCESS Newswire / November 18, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it is initi ...
The Healthy @Reader's Digest on MSN
New UPenn Study: A Popular Blood Pressure Drug Could Also Slow This Aggressive Cancer
A long-trusted blood pressure medication could also show some effect to stop the growth of tumors, found a highly trained ...
Onlymyhealth on MSN
Growth of Aggressive Cancer Can Be Slowed By a Common Blood Pressure Drug: Research
In a surprising turn of scientific discovery, a longstanding blood pressure medication may offer new hope in the fight against fast-growing cancers. Recent laboratory research has revealed that ...
Rakovina Therapeutics Inc. ('Rakovina” or the 'Company”) (TSX-V: RKV)(FSE: 7JO0) a biopharmaceutical company advancing cancer therapies through AI-enabled drug discovery, today announced that its ...
A Western-led interdisciplinary research team is using artificial intelligence (AI) to target a potentially harmful enzyme found in the human body ...
Scientists accidentally discovered how an old blood pressure drug hydralazine could fight aggressive brain cancer by ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week.
A Penn-led team has revealed how hydralazine, one of the world's oldest blood pressure drugs and a mainstay treatment for ...
For rare diseases, AI-driven repurposing fills a critical gap. With more than 7000 rare diseases and only a small percentage ...
One person's side effect could be another person's treatment if we expand our perspective on small molecule drug targets, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback